Literature DB >> 25516547

Impaired cardiac energy metabolism in embryos lacking adrenergic stimulation.

Candice N Baker1, Sarah A Gidus1, George F Price2, Jessica N R Peoples1, Steven N Ebert3.   

Abstract

As development proceeds from the embryonic to fetal stages, cardiac energy demands increase substantially, and oxidative phosphorylation of ADP to ATP in mitochondria becomes vital. Relatively little, however, is known about the signaling mechanisms regulating the transition from anaerobic to aerobic metabolism that occurs during the embryonic period. The main objective of this study was to test the hypothesis that adrenergic hormones provide critical stimulation of energy metabolism during embryonic/fetal development. We examined ATP and ADP concentrations in mouse embryos lacking adrenergic hormones due to targeted disruption of the essential dopamine β-hydroxylase (Dbh) gene. Embryonic ATP concentrations decreased dramatically, whereas ADP concentrations rose such that the ATP/ADP ratio in the adrenergic-deficient group was nearly 50-fold less than that found in littermate controls by embryonic day 11.5. We also found that cardiac extracellular acidification and oxygen consumption rates were significantly decreased, and mitochondria were significantly larger and more branched in adrenergic-deficient hearts. Notably, however, the mitochondria were intact with well-formed cristae, and there was no significant difference observed in mitochondrial membrane potential. Maternal administration of the adrenergic receptor agonists isoproterenol or l-phenylephrine significantly ameliorated the decreases in ATP observed in Dbh-/- embryos, suggesting that α- and β-adrenergic receptors were effective modulators of ATP concentrations in mouse embryos in vivo. These data demonstrate that adrenergic hormones stimulate cardiac energy metabolism during a critical period of embryonic development.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  adrenergic hormones; glycolysis; heart failure; metabolism; mitochondria

Mesh:

Substances:

Year:  2014        PMID: 25516547      PMCID: PMC4346738          DOI: 10.1152/ajpendo.00267.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  58 in total

1.  Myocardial metabolism of glucose, lactic acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads.

Authors:  A CARLSTEN; B HALLGREN; G R JA GENBUR; A SVANBORG; L WERKO
Journal:  Verh Dtsch Ges Kreislaufforsch       Date:  1961

2.  Inactivation and activation of liver phosphorylase.

Authors:  E W SUTHERLAND; W D WOSILAIT
Journal:  Nature       Date:  1955-01-22       Impact factor: 49.962

3.  Unesterified fatty acid in human blood plasma.

Authors:  R S GORDON; A CHERKES
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

4.  Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.

Authors:  Marie Lagouge; Carmen Argmann; Zachary Gerhart-Hines; Hamid Meziane; Carles Lerin; Frederic Daussin; Nadia Messadeq; Jill Milne; Philip Lambert; Peter Elliott; Bernard Geny; Markku Laakso; Pere Puigserver; Johan Auwerx
Journal:  Cell       Date:  2006-11-16       Impact factor: 41.582

Review 5.  Principal substrates of fetal metabolism.

Authors:  F C Battaglia; G Meschia
Journal:  Physiol Rev       Date:  1978-04       Impact factor: 37.312

6.  Relaxin prevents the development of severe acute pancreatitis.

Authors:  Laura Iris Cosen-Binker; Marcelo Gustavo Binker; Rodica Cosen; Gustavo Negri; Osvaldo Tiscornia
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

7.  Mitochondrial bioenergetics and structural network organization.

Authors:  Giovanni Benard; Nadège Bellance; Dominic James; Philippe Parrone; Helder Fernandez; Thierry Letellier; Rodrigue Rossignol
Journal:  J Cell Sci       Date:  2007-02-13       Impact factor: 5.285

8.  Targeted insertion of the Cre-recombinase gene at the phenylethanolamine n-methyltransferase locus: a new model for studying the developmental distribution of adrenergic cells.

Authors:  Steven N Ebert; Qi Rong; Steven Boe; Robert P Thompson; Alexander Grinberg; Karl Pfeifer
Journal:  Dev Dyn       Date:  2004-12       Impact factor: 3.780

Review 9.  The PPAR trio: regulators of myocardial energy metabolism in health and disease.

Authors:  Jose A Madrazo; Daniel P Kelly
Journal:  J Mol Cell Cardiol       Date:  2008-04-04       Impact factor: 5.000

10.  Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function.

Authors:  Vanessa J Davies; Andrew J Hollins; Malgorzata J Piechota; Wanfen Yip; Jennifer R Davies; Kathryn E White; Phillip P Nicols; Michael E Boulton; Marcela Votruba
Journal:  Hum Mol Genet       Date:  2007-04-11       Impact factor: 6.150

View more
  6 in total

1.  Metabolomics reveals critical adrenergic regulatory checkpoints in glycolysis and pentose-phosphate pathways in embryonic heart.

Authors:  Jessica N R Peoples; Timmi Maxmillian; Quynh Le; Sergiy M Nadtochiy; Paul S Brookes; George A Porter; Victor L Davidson; Steven N Ebert
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

2.  Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes.

Authors:  Peyton B Sandroni; Kelsey H Fisher-Wellman; Brian C Jensen
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

3.  Complex Regulation of Mitochondrial Function During Cardiac Development.

Authors:  Qiancong Zhao; Qianchuang Sun; Lufang Zhou; Kexiang Liu; Kai Jiao
Journal:  J Am Heart Assoc       Date:  2019-06-19       Impact factor: 5.501

4.  Metabolic Reconfiguration Activates Stemness and Immunomodulation of PDLSCs.

Authors:  Payal Arora; Wen Li; Xiaobin Huang; Wenjing Yu; Ranran Huang; Qian Jiang; Chider Chen
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 6.208

Review 5.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

6.  A modified method for isolation of human cardiomyocytes to model cardiac diseases.

Authors:  Guang-Ran Guo; Liang Chen; Man Rao; Kai Chen; Jiang-Ping Song; Sheng-Shou Hu
Journal:  J Transl Med       Date:  2018-10-22       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.